Infectious Disease testing
The SARS-CoV-2 pandemic has created an enormous challenge for laboratories and communities worldwide. Currently, laboratories require cost-effective and rapid solutions to track the key SARS-CoV-2 variants currently in circulation, globally. While sequencing-based technologies are commonly used, they are highly complex, expensive, and have a long turnaround time.
To meet these challenges, Agena Bioscience® has developed the MassARRAY® SARS-CoV-2 Variant Panel (RUO), the MassARRAY SARS-CoV-2 Panel (EUA, CE-IVD), and the MassARRAY SARS-CoV-2/Flu Panel (RUO). These panels enable accurate, high-throughput, and low-cost detection of SARS-CoV-2, dominant SARS-CoV-2 variants, and influenza RNA.
Agena MassARRAY® SARS-CoV-2 Panel
The MassARRAY® SARS-CoV-2 Panel from Agena Bioscience® enables laboratories to meet the demands of the COVID-19 pandemic with a high-throughput and low-cost assay for the detection of the novel coronavirus, SARS-CoV-2.
MassARRAY SARS-CoV-2 Panel is now available, with：
- ACCURATE DETECTION：Five SARS-CoV-2 assays multiplexed into a single reaction, targeting the nucleocapsid (N) gene and ORF1ab region.
- SCALABLE THROUGHPUT：Process up to thousands of samples per day with a single instrument.
- LOW COST：Low-cost reagents and automated results reporting saves lab resources.
Download the Panel Resources：
Agena MassARRAY® SARS-CoV-2 Variant Panel
MassARRAY® SARS-CoV-2 Variant Panel is Research Use Only. The assay panel sets are available in both 96 and 384 reaction formats to support varying sample throughput. Enables laboratories to overcome these challenges with a high throughput, low-cost and rapid assay for the detection of 36 unique genetic markers and differentiation of 16 key SARS-CoV-2 variants, including Omicron and Delta. Here’s the detectable variants：
| B.1.617 (India) | L452R, E484Q, P681R | B.1.525 (New York) | E484K, H69_V70del, Y144del, Q677H |
| B.1.617.2 (Delta) | T478K, T19R, P681R, L452R | B.1.526 (New York) | E484K, A701V, D253G, L5F, T95I, S477N |
| B.1.1.7 (Alpha) | P681H, N501Y, A570D, H69_V70del, S982A, T716I, Y144del | B.1.526.1 (New York) | D80G, L452R, Y144del |
| B.1.351 (Beta) | N501Y, D80A, D215G, K417N, E484K, A701V, L18F, L242_L244del | B.1.427/B.1.429 (California) | L452R, S13I, W152C |
| P.1 (Gamma) | N501Y, L18F, E484K, K417T | B.1.258 (Putative immune escape) | N439K, H69_V70del |
| P.2 (Brazil) | E484K, K417, A701V, Q677H | Florida | K1191N, Q493K |
| D614G | D614G | Cluster 5/Mink | I692V, Y453F, H69_V70del, N501T |
| B.1.1.529 (Omicron) | Broad USA | Q677P |
Key Assay Features
- GET ACCURATE DETECTION – Detect and differentiate 16 unique SARS-CoV-2 variants, including Omicron and Delta from the Wuhan lineage of SARS-CoV-2.
- MAXIMIZE THROUGHPUT – The 384 format can process up to 1536 samples in 8 hours.
- SIMPLIFY INTERPRETATION – Clear identification of variants of concern without the need for extensive bioinformatics analysis.
- SAVE TIME & MONEY – Low-cost reagents and automated results reporting save lab resources.
Download the panel resources：
Agena MassARRAY® SARS-CoV-2/Flu Panel
With unprecedented sample volumes expected, this flu season poses critical testing challenges for laboratories, which must reliably and efficiently differentiate between SARS-CoV-2 and influenza RNA. This product is available for Research Use Only.
Features:
- MAXIMIZE THROUGHPUT – Process up to thousands of samples in a day with the MassARRAY System.
- ENSURE ACCURATE DETECTION – The panel includes dual SARS-CoV-2 targets for redundancy, and a sophisticated pan-assay design to detect all influenza A subtypes (including H1N1 and H3N2) and influenza B lineages.
- SAVE TIME & MONEY – Low-cost reagents and automated results reporting saves lab resources.